A Big Question Looms for Walgreen

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Even though Walgreen (NYSE: WAG  ) posted record top- and bottom-line numbers for its third fiscal quarter, shares fell by more than 5% as it indicated plans to sever ties with Express Scripts (Nasdaq: ESRX  ) . Up to this point, the pharmacy-benefits manager has contributed about $5.3 billion in annual sales, and investors wondered how Walgreen would buffer the revenue loss.

Express stop
This split-up is reminiscent of Walgreen's contentious fallout with fellow drug retailer CVS Caremark (NYSE: CVS  ) last year, which cost Walgreen nearly $4.5 billion in annual revenue. If the current deal with Express Scripts isn't renewed, it would cut Walgreen's annual revenues by more than 7%. Walgreen now fills more than 20% of U.S. prescriptions, but without the services of Express Scripts, that number is sure to decrease. 

According to Express Scripts, the sticking point is that non-specialty branded medication prices are expected to increase by over 30% and specialty branded medication prices by 50% over the next three years. Express Scripts' planned repayment rate cuts were unacceptable to Walgreen, which said that the rates were below the industry standard.

A look at the quarter
Regardless of this brouhaha, the company has been performing well. Profit jumped by more than 30% on a year-on-year basis, and the company said it's on track to meet its full-year guidance. Revenues for the quarter increased to $18.37 billion, up 6.8% from a year ago, and same-store sales increased 4.1%. Much of this growth was aided by a 6.4% increase in prescription sales, which accounted for more than 65% of total sales. The quarter also brought an increase in customer traffic and average sales, as demand for cough/cold, pain, sleep, and private-brand drugs went up.

Walgreen also opened or acquired 41 new stores during the quarter and expects to close the year with store growth of 2.5%-3%. It recently acquired, which will bring with it more than 3 million customers and 60,000 online-ready products.

The gross margin rose by 0.5 percentage points, aided by higher generic-drug sales and higher front-end sales growth (except prescription drugs). Net income rose 30.2% year over year, to $603 million.

The Foolish bottom line
Walgreen performed well this quarter and should continue growing into its next and final quarter of the year. The effect of its split with Express Scripts, if that indeed happens, may not be felt this fiscal year. How it will react to the split is yet to be seen, but with a number of tie-ups and mergers this year, it may be able to cope with any adversities.

Fool contributor Shubh Datta doesn't own any shares in the companies mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (19)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1511950, ~/Articles/ArticleHandler.aspx, 10/26/2016 12:11:34 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:00 PM
CVS $87.41 Down -0.59 -0.67%
CVS Health CAPS Rating: ****
ESRX $70.07 Up +0.27 +0.39%
Express Scripts CAPS Rating: *****
WBA $82.45 Down -0.66 -0.79%
Walgreens Boots Al… CAPS Rating: ****